BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that it has posted a bond, as authorized by the Munich Higher Regional Court, in order to suspend an injunction ...
News-Medical.Net on MSN
Bruker announces advancements in immunopeptidomics, de novo PTM analysis, and proteoform profiling
HUPO, Bruker Corporation today announced new machine learning additions to Bruker ProteoScape™ software for immunopeptidomics ...
Bruker Corp (NASDAQ:BRKR) shares are trading lower by 6.6% to $67.80 during Thursday’s session after the company announced a public offering of 6 million shares of its common stock. The offering comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback